Ujjwal Ramtekkar's most recent trade in LifeStance Health Group Inc was a trade of 9,519 Common Stock done at an average price of $5.2 . Disclosure was reported to the exchange on June 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LifeStance Health Group Inc | Ujjwal Ramtekkar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.17 per share. | 16 Jun 2025 | 9,519 | 103,916 | - | 5.2 | 49,213 | Common Stock |
| LifeStance Health Group Inc | Ujjwal Ramtekkar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.94 per share. | 05 Jun 2025 | 16,000 | 113,435 | - | 5.9 | 95,040 | Common Stock |
| LifeStance Health Group Inc | Ujjwal Ramtekkar | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.11 per share. | 10 Mar 2025 | 4,346 | 129,435 | - | 7.1 | 30,900 | Common Stock |
| LifeStance Health Group Inc | Ujjwal Ramtekkar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 57,107 | 119,520 | - | 0 | Common Stock | |
| LifeStance Health Group Inc | Ujjwal Ramtekkar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 20,805 | 140,325 | - | 0 | Common Stock | |
| LifeStance Health Group Inc | Ujjwal Ramtekkar | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.59 per share. | 06 Mar 2025 | 6,544 | 133,781 | - | 7.6 | 49,669 | Common Stock |
| LifeStance Health Group Inc | Ujjwal Ramtekkar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 62,413 | 62,413 | - | 0 | Common Stock |